Search for: "Novartis International Pharmaceutical Ltd." Results 1 - 20 of 85
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Apr 2024, 8:42 am by Holman
West-Ward Pharmaceuticals International, Ltd., 923 F.3d 1051 (Fed. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Sanofi as well as with the likely upcoming petition in Novartis Pharm. [read post]
27 Jan 2021, 11:07 am by anne
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
8 Nov 2020, 9:37 am by Anastasiia Kyrylenko
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle | Invalidating a patent after expiry of the patent term? [read post]
2 Jul 2020, 8:41 am by anne
Novartis Foreign Bribery Scheme Novartis AG, the Novartis parent company based in Switzerland, and former Novartis subsidiary Alcon Pte Ltd were alleged to have violated the Foreign Corrupt Practices Act by bribing officials in, respectively, Greece and Vietnam to induce the purchase of Novartis-branded pharmaceuticals and Alcon surgical products, and then falsifying their corporate books and records to conceal the bribes. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
The outcome:West-Ward Pharmaceuticals International Ltd (“WestWard”)1 appeals the decision of the United States DistrictCourt for the District of Delaware holding that claims 1–3of U.S. [read post]
1 Dec 2017, 11:35 am by Nate Nead
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
18 Sep 2017, 1:36 am
O’Malley (Judge, Court of Appeals for the Federal Circuit, USA) explained that currently, there were three avenues to challenge patents in the United States – through the District Courts up to the CAFC, through the International Trade Commission, and through the USPTO Patent and Trademark Appeal Boards (PTAB) to the CAFC. [read post]
2 Jun 2016, 5:23 am by Mary Jane Wilmoth
Banc de Binary Ltd, Oren Shabat Laurent (f/k/a Oren Shabat), Et Binary Options Ltd., Bo Systes Ltd., Seychelles and BDB Services Ltd. [read post]
25 May 2015, 4:15 am
  The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out last week and which Darren reports in timely fashion.* When functionality cuts deep, it can be hard to handle: Yoshida appeal dismissedValentina's back again to pen on General Court's decision in Joined Cases C‑337/12 P to C‑340/12 P Pi-Design AG,… [read post]
18 May 2015, 11:01 am
The Court of Justice of the European Union (CJEU) addresses that issue in Dimensione Direct Sales srl and Michele Labianca v Knoll International SpA, C-516/13 -- and so does Eleonora in this post.* "Now Now, mere reputation is not enough for passing-off" says Supreme CourtIn Starbucks (HK) Limited and another v British Sky Broadcasting Group plc and others [2015] UKSC 31, the UK Supreme Court rejected arguments that it should expand its jurisprudence on… [read post]
11 May 2015, 3:05 pm
 If you were one of those people and missed a batch of Katposts, you can check them all out below.Once again the IPKat is indebted to his good and amiable friend Alberto Bellan, who has sampled all the posts and has this to report:* A Kat visits #INTA15: PreludeThe International Trademark Association (INTA) has held its 137th Meeting in San Diego this year, deep in the sunny south of California. [read post]
3 May 2015, 10:33 pm
******************PREVIOUSLY, ON NEVER TOO LATENever too late 42 [week ending on Sunday 26 April] – C5's annual Pharmaceutical Patent Term Extensions Forum | UPC: patent attorney and client discuss | CJEU’s 2014 report | PUMA v PUDEL | Leaked Digital Single Market Strategy | Again of the EU Patent Package  and alleged dangers| EU TM reform | Is Svensson’s new public ok? [read post]